NCT03757806

Brief Summary

Physical activity improves cognitive function and the ability to perform activities of daily living in people with dementia and reduces caregivers' burden thus, enhancing quality of life of people with dementia and their caregivers. The wish of most people with dementia, and their caregivers, is to live at their home, for as long as possible. However community-dwelling people with dementia have low levels of physical activity, increasing dependency, which often leads to institutionalization. The Lifestyle Integrated Functional Exercise (LiFE) program has been shown to decrease sedentary activity time and dependency in activities of daily living of older people, however, it has never been implemented in people with dementia. LiFE might be promising as it focuses on establishing new behaviors within selected contexts to stimulate physical activity at home. Therefore, a home-based physical activity program, based on LiFE and involving caregivers, LiFE4D, will be implemented and evaluated in community-dwelling people with dementia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 29, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

July 19, 2022

Status Verified

July 1, 2022

Enrollment Period

1.7 years

First QC Date

November 27, 2018

Last Update Submit

July 18, 2022

Conditions

Keywords

DementiaPhysical activityHome-basedLifestyle

Outcome Measures

Primary Outcomes (1)

  • 2 Minute Step test - change in exercise tolerance

    Participants' exercise tolerance will be assessed with the 2 Minute Step Test, counting the number of times the right knee is raised to the level of the mark on the wall or board (half way between the participant's knee and iliac crest). Higher number of repetitions indicate better performance.

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

Secondary Outcomes (16)

  • Addenbrooke's Cognitive Examination III - change in cognitive function

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

  • Brief Balance Evaluation System Test - change in balance

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

  • Brief Physical Activity Assessment tool - change in self-reported physical activity

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

  • Accelerometer-based activity monitors - change in physical activity levels

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

  • Handgrip Dynamometer - change in maximum isometric strength of the hand and forearm muscles

    Assessment at baseline, post (3 months) and 3 months and 6 months follow-up for experimental and control groups.

  • +11 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

The experimental group will receive the LiFE4D in addition to usual care (e.g., pharmacologic treatment).

Other: Experimental group

Control group

NO INTERVENTION

The control group will receive usual care only.

Interventions

LiFE4D is an individualised programme, adapted to the participant's needs/preferences. People with Dementia will receive assistance to increase their physical activity multiple times/day in their everyday tasks with the support/supervision of their caregivers. The programme last for 12 weeks, with a lower face tracking over time with the health professional but replaced by caregivers. The intervention includes face-to-face sessions and phone calls. Face-to-face sessions aim to adapt physical activity to everyday tasks, increase tasks frequency and intensity, monitor progress, clarify doubts, motivate and manage expectations. Phone calls aim to monitor motivation/evolution and clarify doubts.

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a diagnosis of mild/moderate dementia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V); are living at home; are not participating in exercise training; are able to follow instructions and have a caregiver.

You may not qualify if:

  • have been hospitalized in the previous month; present any clinical condition that precludes them to be involved in physical activity; have been taking medication that affect exercise capacity/bone density.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aveiro

Aveiro, 3810-193, Portugal

Location

MeSH Terms

Conditions

DementiaMotor Activity

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Alda S Marques, PhD

    School of Health Sciences of the University of Aveiro (ESSUA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized controlled trial will be conducted. Participants will be randomized to the control group or intervention group. The control group will receive usual care only (e.g., pharmacologic treatment), whilst the experimental group will receive an individualized home-based physical activity program at home (LiFE4D) in addition to usual care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior lecturer, Dr.

Study Record Dates

First Submitted

November 27, 2018

First Posted

November 29, 2018

Study Start

December 1, 2018

Primary Completion

August 1, 2020

Study Completion

May 1, 2021

Last Updated

July 19, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations